GSP Crop Science Makes Q3FY26 Earnings Call Recording Available Post Results
GSP Crop Science Limited has made the audio recording of its Q3FY26 earnings conference call available on the company website following completion of the earnings discussion held on April 17, 2026. The company informed stock exchanges through regulatory filing about recording accessibility, ensuring transparency for stakeholders who want to review the management discussion on strong financial performance including 14% consolidated revenue growth.

*this image is generated using AI for illustrative purposes only.
GSP Crop Science Limited has made the audio recording of its Q3FY26 earnings conference call available on the company website following the completion of the earnings discussion held on April 17, 2026. The company informed stock exchanges BSE and NSE about the recording availability through a regulatory filing under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Conference Call Completion and Recording Access
The earnings call was successfully conducted on Friday, April 17, 2026, where management discussed the company's financial performance for the third quarter and nine months ended December 31, 2025. The audio recording is now accessible through the company's website link provided in the regulatory filing.
| Parameter: | Details |
|---|---|
| Call Date: | Friday, April 17, 2026 |
| Time: | 3:30 PM IST |
| Host: | Equirus Securities |
| Focus: | Q3 & 9M FY26 performance |
| Recording Access: | Company website |
| Filing Date: | April 18, 2026 |
Financial Performance Highlights
The investor presentation revealed strong consolidated financial performance for the nine-month period, with significant growth across key metrics that were discussed during the conference call.
Consolidated Results (9M FY26)
| Metric: | 9M FY25 (₹ Million) | 9M FY26 (₹ Million) | Growth (%) |
|---|---|---|---|
| Revenue: | 9,794 | 11,146 | +14% |
| EBITDA: | 1,168 | 1,538 | +32% |
| PAT: | 596 | 751 | +26% |
| EBITDA Margin: | 11.92% | 13.80% | +188 bps |
| PAT Margin: | 6.09% | 6.74% | +65 bps |
Standalone Performance (9M FY26)
| Metric: | 9M FY25 (₹ Million) | 9M FY26 (₹ Million) | Growth (%) |
|---|---|---|---|
| Revenue: | 10,799 | 11,766 | +9% |
| EBITDA: | 1,058 | 1,296 | +23% |
| PAT: | 533 | 682 | +28% |
| EBITDA Margin: | 9.79% | 11.01% | +122 bps |
| PAT Margin: | 4.93% | 5.80% | +87 bps |
Business Performance Drivers
The revenue growth was primarily driven by increased business in the domestic B2C segment. Key product performance included new product sales of ₹366.00 million and growth in established brands including PCT-410 (₹80.00 million increase), Torch (₹107.00 million increase), Author (₹90.00 million increase), and Runout (₹47.00 million increase).
The company's international business showed strong momentum with 20% growth over the previous year, driven by planned sales in Brazil, USA, and Africa regions. New registrations in Brazil for Chlorpyrifos contributed to improved sales performance.
Regulatory Compliance
The audio recording availability was communicated to both BSE and NSE through proper regulatory channels. Company Secretary & Compliance Officer Kamleshbhai D Patel signed the regulatory filing on April 18, 2026, ensuring compliance with disclosure requirements for post-earnings call documentation.
How will GSP Crop Science's expansion strategy in Brazil, USA, and Africa impact its revenue mix and margin profile in FY27?
What is the company's pipeline of new product launches beyond the ₹366 million achieved in 9M FY26?
Will the strong domestic B2C segment growth momentum be sustainable given increasing competition in the crop protection market?
































